{"transactions":[{"id":1818276,"issuer":{"id":109724,"kind":"organization","name":"Tristar Acquisition I Corp.","symbol":"TRIS"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2023-08-02T06:04:08.000Z","date":"2023-07-18","kind":"other","planned":false,"acquired":false,"shares":19250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-255009), the Class B ordinary shares will automatically convert into Class A ordinary shares (a) automatically at the time of the registrant's initial business combination and (b) at any time and from time to time at the option of the holders thereof. Such conversion will be on a one-for-one basis, subject to adjustment as described therein, and the Class B ordinary shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold pursuant to (i) a securities purchase agreement, dated as of July 18, 2023, by and between the Issuer, Tristar Holdings I LLC (\"Prior Sponsor\") and Navy Sail International Limited and (ii) founder share transfer agreements, each dated as of July 18, 2023, by and between Chunyi (Charlie) Hao and each holder of Class B ordinary shares other than Prior Sponsor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-255009), the Class B ordinary shares will automatically convert into Class A ordinary shares (a) automatically at the time of the registrant's initial business combination and (b) at any time and from time to time at the option of the holders thereof. Such conversion will be on a one-for-one basis, subject to adjustment as described therein, and the Class B ordinary shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-255009), the Class B ordinary shares will automatically convert into Class A ordinary shares (a) automatically at the time of the registrant's initial business combination and (b) at any time and from time to time at the option of the holders thereof. Such conversion will be on a one-for-one basis, subject to adjustment as described therein, and the Class B ordinary shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-255009), the Class B ordinary shares will automatically convert into Class A ordinary shares (a) automatically at the time of the registrant's initial business combination and (b) at any time and from time to time at the option of the holders thereof. Such conversion will be on a one-for-one basis, subject to adjustment as described therein, and the Class B ordinary shares have no expiration date."}],"balance_after":5750,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":19250},"source":{"system":"sec-edgar","filing":"0000899243-23-017714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000089924323017714/doc4.xml","form_type":"4"}},{"id":1982462,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2023-03-02T14:37:51.000Z","date":"2023-02-28","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares disposed of represent a gift/charitable donation, effective February 28, 2023, in which no value was received in return."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":32440,"source":{"system":"sec-edgar","filing":"0001062993-23-005464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/49071/000106299323005464/form4.xml","form_type":"4"}},{"id":2071636,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2023-01-04T17:37:19.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/23."}],"balance_after":380,"source":{"system":"sec-edgar","filing":"0001062993-23-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000106299323000124/form4.xml","form_type":"4"}},{"id":2077296,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2022-12-23T15:18:11.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":15000,"price":501.72,"value":7525800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Shares contributed by the David Jones Jr Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $501.72 per share, using close of business prices on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":42028,"source":{"system":"sec-edgar","filing":"0001062993-22-024440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/49071/000106299322024440/form4.xml","form_type":"4"}},{"id":2077295,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2022-12-23T15:18:11.000Z","date":"2022-04-28","kind":"gift","acquired":false,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares disposed of represent gift/charitable donation effective April 28, 2022, in which no value was received in return."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":57028,"source":{"system":"sec-edgar","filing":"0001062993-22-024440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/49071/000106299322024440/form4.xml","form_type":"4"}},{"id":2446804,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2022-01-05T18:03:14.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 412 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/22."}],"balance_after":412,"source":{"system":"sec-edgar","filing":"0001062993-22-000549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000106299322000549/form4.xml","form_type":"4"}},{"id":2503454,"issuer":{"id":109724,"kind":"organization","name":"Tristar Acquisition I Corp.","symbol":"TRIS"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-11-19T20:06:13.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":25000,"price":11.5,"value":287500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of Class B ordinary shares are subject to potential forfeiture and transfer restrictions by and between the Reporting Person and Tristar Holdings I LLC (\"Sponsor\") pursuant to a Founder Share Purchase Agreement dated November 17, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Class B ordinary shares will automatically convert into Class A ordinary shares on a one-for-one basis for no additional consideration concurrently with or immediately following the consummation of the initial business combination by the Issuer, on a one-for-one basis, subject to the adjustments described in the Issuer's prospectus on Form S-1 filed on October 14, 2021 (the \"Prospectus\"). The Class B ordinary shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Class B ordinary shares will automatically convert into Class A ordinary shares on a one-for-one basis for no additional consideration concurrently with or immediately following the consummation of the initial business combination by the Issuer, on a one-for-one basis, subject to the adjustments described in the Issuer's prospectus on Form S-1 filed on October 14, 2021 (the \"Prospectus\"). The Class B ordinary shares have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"These Class B ordinary shares will automatically convert into Class A ordinary shares on a one-for-one basis for no additional consideration concurrently with or immediately following the consummation of the initial business combination by the Issuer, on a one-for-one basis, subject to the adjustments described in the Issuer's prospectus on Form S-1 filed on October 14, 2021 (the \"Prospectus\"). The Class B ordinary shares have no expiration date."}],"balance_after":25000,"derivative":{"exercise_price":0,"underlying":"Class A ordinary shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-21-011276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000106299321011276/form4.xml","form_type":"4"}},{"id":2564528,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2021-09-20T13:07:53.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":4800,"price":401,"value":1924800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares contributed by the David Jones Jr. Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $401.00 per share, using close of business price on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Includes 453 shares that vested on 12/31/20 and transferred to trust on 1/4/21."}],"balance_after":67925,"source":{"system":"sec-edgar","filing":"0000049071-21-000125","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907121000125/edgar.xml","form_type":"4"}},{"id":2918315,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2021-01-06T14:48:31.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 403 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/21."}],"balance_after":403,"source":{"system":"sec-edgar","filing":"0000049071-21-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907121000010/edgar.xml","form_type":"4"}},{"id":2937140,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2020-12-21T14:47:07.000Z","date":"2020-06-30","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Shares reported represent a gift/chartiable donation, effective June 30, 2020, in which no value was received in return."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":72272,"source":{"system":"sec-edgar","filing":"0000049071-20-000171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907120000171/edgar.xml","form_type":"4"}},{"id":2937139,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2020-12-21T14:47:07.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":5000,"price":392.76,"value":1963800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares contributed by the David Jones Jr Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $392.76 per share, using close of business prices on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":77272,"source":{"system":"sec-edgar","filing":"0000049071-20-000171","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907120000171/edgar.xml","form_type":"4"}},{"id":3197471,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2020-03-24T22:25:48.000Z","date":"2020-03-20","kind":"sale","acquired":false,"shares":5800,"price":256.19,"value":1485902.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Shares contributed by the David Jones Jr Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $256.19 per share, using close of business prices on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":82272,"source":{"system":"sec-edgar","filing":"0000049071-20-000065","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907120000065/edgar.xml","form_type":"4"}},{"id":3326046,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2020-01-03T16:51:03.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 453 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/20."}],"balance_after":1041,"source":{"system":"sec-edgar","filing":"0000049071-20-000004","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907120000004/edgar.xml","form_type":"4"}},{"id":3706948,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2019-01-04T21:10:37.000Z","date":"2017-05-18","kind":"sale","acquired":false,"shares":200,"price":230.0401,"value":46008.02,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee. Amounts reported reflect equal sales and subsequent holdings from each trust on the reported dates that were inadvertently omitted from prior filings."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0000049071-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907119000011/edgar.xml","form_type":"4"}},{"id":3706947,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2019-01-04T21:10:37.000Z","date":"2014-08-11","kind":"sale","acquired":false,"shares":200,"price":120.2401,"value":24048.02,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee. Amounts reported reflect equal sales and subsequent holdings from each trust on the reported dates that were inadvertently omitted from prior filings."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000049071-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907119000011/edgar.xml","form_type":"4"}},{"id":3706946,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2019-01-04T21:10:37.000Z","date":"2014-06-10","kind":"sale","acquired":false,"shares":400,"price":124.4949,"value":49797.96,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee. Amounts reported reflect equal sales and subsequent holdings from each trust on the reported dates that were inadvertently omitted from prior filings."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0000049071-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907119000011/edgar.xml","form_type":"4"}},{"id":3706945,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2019-01-04T21:10:37.000Z","date":"2012-03-16","kind":"sale","acquired":false,"shares":400,"price":86.3206,"value":34528.24,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee. Amounts reported reflect equal sales and subsequent holdings from each trust on the reported dates that were inadvertently omitted from prior filings."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0000049071-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907119000011/edgar.xml","form_type":"4"}},{"id":3706944,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2019-01-04T21:10:37.000Z","date":"2011-11-16","kind":"sale","acquired":false,"shares":600,"price":88.0504,"value":52830.24,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee. Amounts reported reflect equal sales and subsequent holdings from each trust on the reported dates that were inadvertently omitted from prior filings."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000049071-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907119000011/edgar.xml","form_type":"4"}},{"id":3706943,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2019-01-04T21:10:37.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 588 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2019."}],"balance_after":588,"source":{"system":"sec-edgar","filing":"0000049071-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907119000011/edgar.xml","form_type":"4"}},{"id":3891915,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2018-06-18T16:18:33.000Z","date":"2018-06-14","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction represents a gift/charitable donation effective June 14, 2018. This is not a market transaction and no value was received in return for the shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":86826,"source":{"system":"sec-edgar","filing":"0000049071-18-000083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907118000083/edgar.xml","form_type":"4"}},{"id":3955250,"issuer":{"id":167208,"kind":"organization","name":"CONNECTURE INC","symbol":"CNXR"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-04-27T17:09:01.000Z","date":"2018-04-25","kind":"other","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Chrysalis Ventures II L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares were held directly by CV II.  Mr. Jones is a Managing Member of Chrysalis Partners II, LLC, the general partner of CV II. Mr. Jones disclaims beneficial ownership of the shares held by CV II, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-10","underlying":"Common Stock","underlying_shares":618170},"source":{"system":"sec-edgar","filing":"0000899243-18-010891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000089924318010891/doc4.xml","form_type":"4"}},{"id":3955249,"issuer":{"id":167208,"kind":"organization","name":"CONNECTURE INC","symbol":"CNXR"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-04-27T17:09:01.000Z","date":"2018-04-25","kind":"other","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Chrysalis Ventures II L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares were held directly by CV II.  Mr. Jones is a Managing Member of Chrysalis Partners II, LLC, the general partner of CV II. Mr. Jones disclaims beneficial ownership of the shares held by CV II, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_date":"2016-05-02","underlying":"Common Stock","underlying_shares":585160},"source":{"system":"sec-edgar","filing":"0000899243-18-010891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000089924318010891/doc4.xml","form_type":"4"}},{"id":3955248,"issuer":{"id":167208,"kind":"organization","name":"CONNECTURE INC","symbol":"CNXR"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-27T17:09:01.000Z","date":"2018-04-25","kind":"other","acquired":false,"shares":4007162,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Chrysalis Ventures II L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares were held directly by CV II.  Mr. Jones is a Managing Member of Chrysalis Partners II, LLC, the general partner of CV II. Mr. Jones disclaims beneficial ownership of the shares held by CV II, except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-010891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000089924318010891/doc4.xml","form_type":"4"}},{"id":3955247,"issuer":{"id":167208,"kind":"organization","name":"CONNECTURE INC","symbol":"CNXR"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-27T17:09:01.000Z","date":"2018-04-25","kind":"other","acquired":false,"shares":57696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By David A. Jones, Jr. Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 25, 2018, FP Healthcare Merger Sub Corporation (\"Merger Sub\") and FP Healthcare Holdings, Inc. (\"Parent\") completed its merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, each of Mr. Jones and Chrysalis Partners II L.P. (\"CV II\") contributed all of the shares of Common Stock and Preferred Stock, as applicable, held by him or it, as applicable, (the \"Rollover Shares\") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-010891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000089924318010891/doc4.xml","form_type":"4"}},{"id":4116017,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2018-01-03T21:14:19.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 658 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2018."}],"balance_after":1434,"source":{"system":"sec-edgar","filing":"0000049071-18-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907118000011/edgar.xml","form_type":"4"}},{"id":4225176,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2017-08-25T18:19:56.000Z","date":"2017-08-23","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction represents a gift/charitable donation effective August 23, 2017. This is not a market transaction and no value was received in return for the shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"On March 22, 2017 Mr. Jones transferred 27,050 indirect shares from his grantor retained annuity trust (GRAT #2) to his revocable trust account. On June 2, 2017 he transferred 52,198 indirect shares from his grantor retained annuity trust (GRAT #1) to his revocable trust account. These transactions were not reportable pursuant to SEC rule 16a-13. GRAT #1 and GRAT #2 have a balance of 0 shares, and therefore were removed from Table I reporting. On August 23, 2017 he gifted 4,000 shares from his revocable trust account. This reflects the balance following these three transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock."}],"balance_after":96050,"source":{"system":"sec-edgar","filing":"0000049071-17-000157","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907117000157/edgar.xml","form_type":"4"}},{"id":4386848,"issuer":{"id":167208,"kind":"organization","name":"CONNECTURE INC","symbol":"CNXR"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2017-03-14T19:10:41.000Z","date":"2017-03-10","kind":"purchase","acquired":true,"shares":1000,"price":1000,"value":1000000.0,"ownership":{"direct":false,"nature":"By Chrysalis Ventures II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Convertible Preferred Stock is convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially is $1.91 per share, subject to customary adjustments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Convertible Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held directly by Chrysalis Ventures II, L.P. (\"CV II\"). Mr. Jones is a Managing Member of Chrysalis Partners II, LLC, the general partner of CV II.  Mr. Jones disclaims beneficial ownership of the shares held by CV II, except to the extent of any pecuniary interest therein."}],"balance_after":1000,"derivative":{"exercise_date":"2017-03-10","underlying":"Common Stock","underlying_shares":523560},"source":{"system":"sec-edgar","filing":"0001209191-17-020635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1025393/000120919117020635/doc4.xml","form_type":"4"}},{"id":4430303,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2017-02-23T16:58:17.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":27000,"price":205.0433,"value":5536169.1,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Shares sold at prices ranging from $204.51 to $206.43."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by grantor retained annuity trust (GRAT #2) exempt from Rule 16(a)-13, on which reporting person is the sole trustee."}],"balance_after":27050,"source":{"system":"sec-edgar","filing":"0000049071-17-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907117000040/edgar.xml","form_type":"4"}},{"id":4506580,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2017-01-04T21:21:38.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017."}],"balance_after":761,"source":{"system":"sec-edgar","filing":"0000049071-17-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907117000003/edgar.xml","form_type":"4"}},{"id":4575926,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2016-10-24T17:47:46.000Z","date":"2016-10-21","kind":"gift","acquired":true,"shares":54050,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"On September 17th, 2015, the reporting person transferred 106,248 shares of Humana Inc. common stock from his revocable trust to a new grantor retained annuity trust (GRAT) exempt from Rule 16(a)-13, on which he is the sole trustee. On October 21, 2016 reporting person transferred 54,050 shares from the GRAT to his revocable trust."}],"balance_after":54050,"source":{"system":"sec-edgar","filing":"0000049071-16-000180","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907116000180/edgar.xml","form_type":"4"}},{"id":4575925,"issuer":{"id":1429,"kind":"organization","name":"HUMANA INC","symbol":"HUM"},"owners":[{"id":110946,"kind":"person","name":"JONES DAVID A JR/KY","position":1,"cik":"0001025393","reported_name":"JONES DAVID A JR/KY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Humana Common","published_at":"2016-10-24T17:47:46.000Z","date":"2016-10-21","kind":"gift","acquired":false,"shares":54050,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"On September 17th, 2015, the reporting person transferred 106,248 shares of Humana Inc. common stock from his revocable trust to a new grantor retained annuity trust (GRAT) exempt from Rule 16(a)-13, on which he is the sole trustee. On October 21, 2016 reporting person transferred 54,050 shares from the GRAT to his revocable trust."}],"balance_after":52198,"source":{"system":"sec-edgar","filing":"0000049071-16-000180","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/49071/000004907116000180/edgar.xml","form_type":"4"}}]}